MedTrace Logo

Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions

NCT01457196 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2798

Last updated 2019-12-30

Study results available
· View outcomes & findings →

Summary

The primary objective of this specimen correlative study is two-fold: to provide a mechanism for the association of known molecular alterations with clinical outcomes, and to provide rapid genetic profiling of alterations with known clinical utility using tumor and germline specimens to support treatment decisions.

Conditions

Interventions

DIAGNOSTIC_TEST

Tumor Genetic Sequencing

This study will look at genetic material from a sample of the subjects tumor, look at certain changes in the genetic material, and see if these changes are related to the subjects cancer.

Sponsors & Collaborators

  • UNC Lineberger Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • H. Shelton Earp, MD · University of North Carolina, Chapel Hill

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2018-06-06
Completion
2018-06-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01457196 on ClinicalTrials.gov